The Cannaisseur Group, Inc. (TCRG)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
The Cannaisseur Group, Inc. (TCRG) trades at $0.00 with AI Score 44/100 (Grade C). The Cannaisseur Group, Inc. operates in the wellness sector, developing and selling functional products. Market cap: $83,055, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for TCRG: TCRG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TCRG against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
TCRG: the 1 perspectives are evenly split.
How is this calculated? →The Cannaisseur Group, Inc. (TCRG) Healthcare & Pipeline Overview
The Cannaisseur Group, Inc., operating through Atlanta CBD, Inc., develops and markets functional wellness products, including CBD offerings, directly to consumers. Founded in 2020 and based in Atlanta, the company navigates the competitive landscape of the drug manufacturers industry with a focus on functional consumer goods.
What Is the Investment Thesis for TCRG?
The Cannaisseur Group, Inc. presents a speculative investment opportunity within the burgeoning CBD wellness market. With a market capitalization of 83K, the company is a micro-cap stock with high beta of -139.46, indicating extreme volatility. The company's direct-to-consumer model through Atlanta CBD, Inc. offers potential for margin control, but also relies heavily on effective online marketing and brand building. Key catalysts include successful new product launches and expansion of the online customer base. However, investors should be aware of the risks associated with OTC-listed companies, including limited liquidity and disclosure. The company's success hinges on its ability to navigate the regulatory landscape and differentiate itself in a competitive market.
Based on FMP financials and quantitative analysis
TCRG Key Highlights
- Market capitalization of 83K, classifying it as a micro-cap stock.
- Operates through its subsidiary, Atlanta CBD, Inc., focusing on CBD wellness products.
- Direct-to-consumer sales model via the company's website.
- Beta of -139.46 indicates extreme volatility relative to the market.
- No dividend yield, reflecting a focus on reinvesting earnings for growth.
Who Are TCRG's Competitors?
TCRG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ORINY Orion Oyj | $38.86 | +0.00% | $21.87B | 64 |
| MRK Merck & Co., Inc. | $126.78 | -2.15% | $313.12B | 64 |
| ORINF Orion Oyj | $82.75 | +0.00% | $11.66B | 63 |
| AZN AstraZeneca PLC | $190.16 | -2.56% | $294.91B | 61 |
| SNPHY Santen Pharmaceutical Co., Ltd. | $13.90 | +3.08% | $4.47B | 44 |
| GRFS Grifols, S.A. is a global healthcare company focused on plasma-derived medicines and other innovative solutions. The company | $7.21 | +0.77% | $6.10B | 45 |
| MAYNF Mayne Pharma Group Limited | $1.65 | +0.00% | $134.06M | 43 |
| MIRA MIRA Pharmaceuticals, Inc. | $0.95 | +0.49% | $39.90M | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TCRG's Key Strengths?
- Direct-to-consumer sales model
- Focus on CBD wellness products
- Portfolio of functional beverages and nutraceuticals
- Established online presence
What Are TCRG's Weaknesses?
- Limited market capitalization
- High beta indicating extreme volatility
- Dependence on online sales
- Small number of employees
What Could Drive TCRG Stock Higher?
- Potential new product launches in the CBD wellness category.
- Increasing consumer demand for CBD-infused products.
- Expansion of online marketing efforts to drive sales.
What Are the Key Risks for TCRG?
- Evolving regulatory landscape for CBD products.
- Intense competition in the CBD wellness market.
- Economic downturn affecting consumer spending.
- Limited liquidity due to OTC listing.
- High beta indicating extreme volatility.
What Are the Growth Opportunities for TCRG?
- Expansion of Product Line: The Cannaisseur Group can expand its product line to include a wider range of CBD-infused products, such as topicals, edibles, and pet products. The global CBD market is projected to reach $47.22 billion by 2028, presenting a significant opportunity for revenue growth. Timeline: Within the next 1-2 years, the company can introduce new product categories based on market demand and regulatory approvals.
- Strategic Partnerships: Forming strategic partnerships with established retailers or distributors can significantly expand The Cannaisseur Group's market reach. Collaborating with wellness centers, gyms, or health food stores can provide access to new customer segments and increase brand visibility. Timeline: Establishing partnerships within the next year can accelerate market penetration and revenue growth.
- Geographic Expansion: The Cannaisseur Group can expand its operations beyond its current base in Atlanta, Georgia, to target new geographic markets. Focusing on states with favorable CBD regulations and high consumer demand can drive revenue growth. Timeline: Expanding into new states within the next 2-3 years can significantly increase the company's customer base and market share.
- Enhanced Online Marketing: Investing in enhanced online marketing strategies, including search engine optimization (SEO), social media marketing, and influencer collaborations, can drive traffic to The Cannaisseur Group's website and increase sales. A strong online presence is crucial for reaching a wider audience and building brand awareness. Timeline: Implementing enhanced marketing strategies within the next 6-12 months can improve online visibility and drive sales growth.
- Subscription Model: Implementing a subscription-based model for its CBD wellness products can generate recurring revenue and foster customer loyalty. Offering discounts and exclusive products to subscribers can incentivize participation and increase customer retention. Timeline: Launching a subscription model within the next year can provide a stable revenue stream and enhance customer engagement.
What Opportunities Does TCRG Have?
- Expansion of product line
- Strategic partnerships with retailers
- Geographic expansion to new markets
- Enhanced online marketing strategies
What Threats Does TCRG Face?
- Evolving regulatory landscape for CBD products
- Intense competition in the CBD wellness market
- Potential changes in consumer preferences
- Economic downturn affecting consumer spending
What Are TCRG's Competitive Advantages?
- Direct-to-consumer model allows for margin control.
- Focus on CBD wellness products in a growing market.
- Brand building through online presence.
- Portfolio of functional beverages, nutraceuticals, and consumer goods.
What Does TCRG Do?
The Cannaisseur Group, Inc., established in 2020 and headquartered in Atlanta, Georgia, operates in the wellness sector through its subsidiary, Atlanta CBD, Inc. The company focuses on the development and distribution of functional products, catering to the growing consumer interest in wellness solutions. Its product portfolio encompasses functional beverages, nutraceuticals, and various consumer goods, all centered around the benefits of CBD. Atlanta CBD, Inc. serves as the primary operational arm, handling the creation, marketing, and sales of the company's CBD wellness products. These products are offered directly to consumers through the company's website, allowing for a direct-to-consumer business model that bypasses traditional retail channels. This approach enables the company to maintain control over its brand image and customer experience. The Cannaisseur Group's strategic focus is on leveraging the increasing acceptance and demand for CBD-infused products in the wellness market. By offering a range of functional products, the company aims to appeal to a broad customer base seeking natural and holistic health solutions. While still in its early stages, The Cannaisseur Group is positioning itself to capitalize on the expanding market for CBD wellness products.
What Products and Services Does TCRG Offer?
- Develops functional wellness products
- Offers a variety of CBD wellness products
- Operates through its subsidiary, Atlanta CBD, Inc.
- Sells products directly to consumers via its website
- Focuses on functional beverages, nutraceuticals, and consumer goods
- Markets CBD-infused products for health and wellness
How Does TCRG Make Money?
- Develops and manufactures CBD wellness products.
- Sells products directly to consumers through its website.
- Focuses on functional beverages, nutraceuticals, and consumer goods.
- Generates revenue through online sales of CBD products.
What Industry Does TCRG Operate In?
The Cannaisseur Group operates within the rapidly expanding CBD wellness market, which has seen significant growth due to increasing consumer awareness and acceptance of CBD products. This market includes various product categories such as beverages, nutraceuticals, and personal care items. The industry is characterized by a fragmented competitive landscape, with numerous small to medium-sized companies vying for market share. The Cannaisseur Group's direct-to-consumer model positions it to capture a segment of this growing market, but it faces competition from established players and evolving regulatory frameworks.
Who Are TCRG's Key Customers?
- Individuals seeking wellness solutions.
- Consumers interested in CBD-infused products.
- Customers who prefer direct-to-consumer online shopping.
- Health-conscious individuals looking for functional beverages and nutraceuticals.
Company Profile
The Cannaisseur Group, Inc. operates in the Drug Manufacturers - General industry within the Healthcare sector. It is headquartered in Atlanta, US. The company is led by CEO Floretta Gogo. TCRG has traded publicly since 2025.
The Cannaisseur Group, Inc. (TCRG) Valuation Context
Relative to its peer group, TCRG's quantitative score of 44/100 is below the peer average of 59/100.
TCRG Financials
Bull Case vs Bear Case
Bull Case
- Insiders seem to be positioning themselves favorably, which often signals confidence in the company's future prospects.
- Recent community chatter suggests a growing belief in the company's long-term vision.
- Market perception seems to be shifting towards recognizing the unique value proposition of The Cannaisseur Group.
- Positive developments in the broader cannabis industry could act as a tailwind for TCRG.
Bear Case
- Some insiders might be selling shares for personal reasons unrelated to the company's performance, so insider activity isn't always a clear signal.
- A segment of the community expresses concerns about the company's ability to execute its growth strategy effectively.
- Market perception can be fickle, and negative news or industry headwinds could quickly change the narrative.
- Regulatory uncertainties in the cannabis industry remain a significant risk factor for companies like TCRG.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
TCRG Latest News
No recent news available for TCRG.
TCRG Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TCRG.
Price Targets
Wall Street price target analysis for TCRG.
TCRG MoonshotScore
What does this score mean?
The MoonshotScore rates TCRG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Floretta Gogo
CEO
Floretta Gogo is the CEO of The Cannaisseur Group, Inc. Her background includes managing small teams and guiding the company's strategic direction in the competitive wellness market. With a focus on developing and marketing CBD wellness products, she oversees the company's operations and growth initiatives. Her leadership is crucial in navigating the evolving regulatory landscape and market dynamics of the CBD industry.
Track Record: Under Floretta Gogo's leadership, The Cannaisseur Group has focused on establishing a direct-to-consumer sales model through its subsidiary, Atlanta CBD, Inc. Key achievements include developing a portfolio of functional beverages, nutraceuticals, and consumer goods centered around CBD. Her strategic decisions have aimed to capitalize on the increasing consumer demand for CBD wellness products.
TCRG OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that The Cannaisseur Group may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier involves higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to OTC listing.
- Potential for wider bid-ask spreads.
- Lack of regulatory oversight compared to major exchanges.
- Limited financial disclosure and transparency.
- Higher price volatility.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their experience.
- Evaluate the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Check for any outstanding legal issues or litigation.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company's incorporation in 2020.
- Operation through subsidiary Atlanta CBD, Inc.
- Direct-to-consumer sales model via website.
- Focus on CBD wellness products.
- Presence in the growing CBD market.
Common Questions About TCRG (Healthcare)
What does The Cannaisseur Group, Inc. do?
The Cannaisseur Group, Inc., through its subsidiary Atlanta CBD, Inc., operates as a wellness company focused on developing and distributing functional products. Its core business revolves around CBD wellness products, including functional beverages, nutraceuticals, and various consumer goods. The company utilizes a direct-to-consumer model, selling its products directly to customers through its website. This approach allows The Cannaisseur Group to maintain control over its brand and customer experience while capitalizing on the growing demand for CBD-infused wellness solutions.
What do analysts say about TCRG stock?
As of 2026-03-17, there is no available analyst coverage or consensus for The Cannaisseur Group, Inc. (TCRG). Given its micro-cap status and OTC listing, the company may not be actively tracked by major financial analysts. Investors should conduct their own thorough research and consider the risks associated with investing in small, thinly traded companies. Key valuation metrics and growth considerations are not readily available due to the lack of analyst coverage.
What are the main risks for TCRG?
The Cannaisseur Group, Inc. faces several risks inherent to its business and market position. The evolving regulatory landscape for CBD products poses a significant challenge, as changes in regulations could impact the legality and marketability of its products. Intense competition in the CBD wellness market requires the company to differentiate itself and maintain a competitive edge. Additionally, the company's OTC listing results in limited liquidity and higher price volatility. An economic downturn could also affect consumer spending on wellness products, impacting the company's revenue.
What are the key factors to evaluate for TCRG?
The Cannaisseur Group, Inc. (TCRG) holds an AI score of 44/100 (low). Not financial advice.
How frequently does TCRG data refresh on this page?
TCRG prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven TCRG's recent stock price performance?
The Cannaisseur Group, Inc. (TCRG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Direct-to-consumer sales model. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TCRG overvalued or undervalued right now?
Valuing The Cannaisseur Group, Inc. (TCRG) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying TCRG?
Before investing in The Cannaisseur Group, Inc. (TCRG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of 2026-03-17.
- OTC market data may be limited and less reliable than major exchanges.
- AI analysis pending for TCRG.